Thomas F. Scanlin

1.6k total citations
51 papers, 1.2k citations indexed

About

Thomas F. Scanlin is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Nutrition and Dietetics. According to data from OpenAlex, Thomas F. Scanlin has authored 51 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pulmonary and Respiratory Medicine, 14 papers in Molecular Biology and 14 papers in Nutrition and Dietetics. Recurrent topics in Thomas F. Scanlin's work include Cystic Fibrosis Research Advances (37 papers), Neonatal Respiratory Health Research (17 papers) and Infant Nutrition and Health (10 papers). Thomas F. Scanlin is often cited by papers focused on Cystic Fibrosis Research Advances (37 papers), Neonatal Respiratory Health Research (17 papers) and Infant Nutrition and Health (10 papers). Thomas F. Scanlin collaborates with scholars based in United States, Netherlands and France. Thomas F. Scanlin's co-authors include Mary Catherine Glick, Jean Tomezsko, Deborah A. Kawchak, Virginia A. Stallings, Virginia A. Stallings, Daniel Klink, Huaqing Zhao, Avital Cnaan, Babette S. Zemel and Andrew D. Rhim and has published in prestigious journals such as Annals of Internal Medicine, American Journal of Clinical Nutrition and Biochemistry.

In The Last Decade

Thomas F. Scanlin

50 papers receiving 1.2k citations

Peers

Thomas F. Scanlin
A Rüdeberg Switzerland
Kathleen A. Hilliard United States
Lauren M. Dimapasoc United States
Theresa Dubowski United States
Jonathan B. Zuckerman United States
A Rüdeberg Switzerland
Thomas F. Scanlin
Citations per year, relative to Thomas F. Scanlin Thomas F. Scanlin (= 1×) peers A Rüdeberg

Countries citing papers authored by Thomas F. Scanlin

Since Specialization
Citations

This map shows the geographic impact of Thomas F. Scanlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas F. Scanlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas F. Scanlin more than expected).

Fields of papers citing papers by Thomas F. Scanlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas F. Scanlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas F. Scanlin. The network helps show where Thomas F. Scanlin may publish in the future.

Co-authorship network of co-authors of Thomas F. Scanlin

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas F. Scanlin. A scholar is included among the top collaborators of Thomas F. Scanlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas F. Scanlin. Thomas F. Scanlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carayannopoulos, Mary O., et al.. (2023). Severe lung disease in children with cystic fibrosis missed in newborn screening. Pediatric Pulmonology. 59(1). 163–168. 3 indexed citations
2.
Rhim, Andrew D., et al.. (2004). Altered terminal glycosylation and the pathophysiology of CF lung disease. Journal of Cystic Fibrosis. 3. 95–96. 17 indexed citations
3.
Klink, Daniel, Qian‐Chun Yu, Mary Catherine Glick, & Thomas F. Scanlin. (2003). Lactosylated poly-l-lysine targets a potential lactose receptor in cystic fibrosis and non-cystic fibrosis airway epithelial cells. Molecular Therapy. 7(1). 73–80. 28 indexed citations
4.
Kamath, Binita M., et al.. (2003). A girl with cystic fibrosis and failure to thrive. The Journal of Pediatrics. 143(1). 115–119. 1 indexed citations
5.
Glick, Mary Catherine, et al.. (2001). Activity of fucosyltransferases and altered glycosylation in cystic fibrosis airway epithelial cells. Biochimie. 83(8). 743–747. 45 indexed citations
6.
Klink, Daniel, et al.. (2001). Nuclear Translocation of Lactosylated Poly-l-lysine/cDNA Complex in Cystic Fibrosis Airway Epithelial Cells. Molecular Therapy. 3(6). 831–841. 48 indexed citations
7.
Stettler, Nicolas, Deborah A. Kawchak, Kathleen J. Propert, et al.. (2000). Prospective evaluation of growth, nutritional status, and body composition in children with cystic fibrosis. American Journal of Clinical Nutrition. 72(2). 407–413. 42 indexed citations
8.
Rhim, Andrew D., et al.. (2000). Terminal glycosylation of cystic fibrosis airway epithelial cells. Glycoconjugate Journal. 17(6). 385–391. 20 indexed citations
9.
Stettler, Nicolas, et al.. (2000). A Prospective Study of Body Composition Changes in Children with Cystic Fibrosis. Annals of the New York Academy of Sciences. 904(1). 406–409. 10 indexed citations
10.
Kollen, Wouter J.W., Andrew E. Mulberg, Xiaofang Wei, et al.. (1999). High-Efficiency Transfer of Cystic Fibrosis Transmembrane Conductance Regulator cDNA into Cystic Fibrosis Airway Cells in Culture Using Lactosylated Polylysine as a Vector. Human Gene Therapy. 10(4). 615–622. 32 indexed citations
11.
Fung, Ellen B., Elizabeth M. Barden, Dror Wasserman, et al.. (1999). A Six-Month Study of Growth and Energy Expenditure in Children with Cystic Fibrosis Taking a Pulmonary Inhalation Medication (rhDNase). Journal of the American College of Nutrition. 18(4). 330–338. 1 indexed citations
12.
Kollen, Wouter J.W., Patrick Erbacher, Patrick Midoux, et al.. (1997). Glycosylated Polylysines. CHEST Journal. 111(6). 95S–96S. 2 indexed citations
13.
Kollen, Wouter J.W., Patrick Midoux, Patrick Erbacher, et al.. (1996). Gluconoylated and Glycosylated Polylysines As Vectors for Gene Transfer into Cystic Fibrosis Airway Epithelial Cells. Human Gene Therapy. 7(13). 1577–1586. 40 indexed citations
14.
Zemel, Babette S., Deborah A. Kawchak, Avital Cnaan, et al.. (1996). Prospective Evaluation of Resting Energy Expenditure, Nutritional Status, Pulmonary Function, and Genotype in Children with Cystic Fibrosis. Pediatric Research. 40(4). 578–586. 70 indexed citations
15.
Wei, Xiaofang, R Eisman, Andrew E. Mulberg, et al.. (1996). Turnover of the cystic fibrosis transmembrane conductance regulator (CFTR): Slow degradation of wild-type and ΔF508 CFTR in surface membrane preparations of immortalized airway epithelial cells. Journal of Cellular Physiology. 168(2). 373–384. 28 indexed citations
16.
Tomezsko, Jean, Virginia A. Stallings, Deborah A. Kawchak, et al.. (1994). Energy Expenditure and Genotype of Children with Cystic Fibrosis. Pediatric Research. 35(4). 451–460. 68 indexed citations
17.
Fortina, Paolo, Teresa Parrella, Jeffrey A. Kant, et al.. (1992). Non-radioactive detection of the most common mutations in the cystic fibrosis transmembrane conductance regulator gene by multiplex allele-specific polymerase chain reaction. Human Genetics. 90(4). 375–8. 11 indexed citations
18.
Fortina, Paolo, Teresa Parrella, Eric Rappaport, et al.. (1992). Fluorescence-based, multiplex allele-specific PCR (MASPCR) detection of the ΔF508 deletion in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Molecular and Cellular Probes. 6(4). 353–356. 9 indexed citations
19.
Robinson, Cynthia B., et al.. (1988). Lack of proteolytic processing of α‐L‐fucosidase in human skin fibroblasts. Journal of Cellular Physiology. 137(3). 411–420. 13 indexed citations
20.
Voynow, Judith A., Thomas F. Scanlin, & Mary Catherine Glick. (1988). A quantitative method for GDP-l-Fuc:N-acetyl-β-d-glucosaminide α1→6fucosyltransferase activity with lectin affinity chromatography. Analytical Biochemistry. 168(2). 367–373. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026